RxDoctor Payments Data

Salman Sagarwala, MD

Interventional Pain Medicine · Chicago, ILNPI 1518311422

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (48.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medtronic at 48.0% of the total. Among interventional pain medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,066in general payments, 2019–2025

Across 116 payments — averaging $224.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$13K
  • Abbott$8K
  • Nevro Corp.$2K
  • Spinal Simplicity, LLC$1K
  • Stryker$514
  • Globus Medical$349
  • plus $1K from 9 others

What the payments were for

  • Speaking & faculty fees$4,35017%
  • Grants$12,50048%
  • Travel & lodging$3,28813%
  • Food & beverage$5,92823%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,066 in reported general payments places this provider in the 90th percentile of 93 interventional pain medicine providers in Illinois.

See all interventional pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$39,857
Medicare patients
92
Services billed
354

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin101$3,613
Buprenorphine13$3,196
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen112$2,522
Celecoxib41$2,281
Diclofenac Sodium11$1,931
Gabapentin140$1,690
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen35$605
Cyclobenzaprine Hcl31$519
Acetaminophen-CodeineAcetaminophen With Codeine31$473
Tizanidine Hcl49$451
Tramadol Hcl77$335
Meloxicam93$231
Duloxetine Hcl11$30

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →